|
Co-Prenessa 4 mg /1,25 mg tbl 100x4 mg /1,25 mg (OPA/Al/PVC/Al)
4 mg /1,25 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 4 mg /1,25 mg tbl 100x4 mg /1,25 mg (PVC/PE/PVDC/Al)
4 mg /1,25 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 4 mg /1,25 mg tbl 14x4 mg /1,25 mg (OPA/Al/PVC/Al)
4 mg /1,25 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 4 mg /1,25 mg tbl 14x4 mg /1,25 mg (PVC/PE/PVDC/Al)
4 mg /1,25 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 4 mg /1,25 mg tbl 20x4 mg /1,25 mg (OPA/Al/PVC/Al)
4 mg /1,25 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 4 mg /1,25 mg tbl 20x4 mg /1,25 mg (PVC/PE/PVDC/Al)
4 mg /1,25 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 4 mg /1,25 mg tbl 28x4 mg /1,25 mg (OPA/Al/PVC/Al)
4 mg /1,25 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 4 mg /1,25 mg tbl 28x4 mg /1,25 mg (PVC/PE/PVDC/Al)
4 mg /1,25 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 4 mg /1,25 mg tbl 30x4 mg /1,25 mg (OPA/Al/PVC/Al)
4 mg /1,25 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 4 mg /1,25 mg tbl 30x4 mg /1,25 mg (PVC/PE/PVDC/Al)
4 mg /1,25 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 4 mg /1,25 mg tbl 50x4 mg /1,25 mg (OPA/Al/PVC/Al)
4 mg /1,25 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 4 mg /1,25 mg tbl 50x4 mg /1,25 mg (PVC/PE/PVDC/Al)
4 mg /1,25 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 4 mg /1,25 mg tbl 56x4 mg /1,25 mg (OPA/Al/PVC/Al)
4 mg /1,25 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 4 mg /1,25 mg tbl 56x4 mg /1,25 mg (PVC/PE/PVDC/Al)
4 mg /1,25 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 4 mg /1,25 mg tbl 60x4 mg /1,25 mg (OPA/Al/PVC/Al)
4 mg /1,25 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 4 mg /1,25 mg tbl 60x4 mg /1,25 mg (PVC/PE/PVDC/Al)
4 mg /1,25 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 4 mg /1,25 mg tbl 90x4 mg /1,25 mg (OPA/Al/PVC/Al)
4 mg /1,25 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 4 mg /1,25 mg tbl 90x4 mg /1,25 mg (PVC/PE/PVDC/Al)
4 mg /1,25 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 8 mg/2,5 mg tbl 100x8 mg/2,5 mg (blis.OPA/Al/PVC/Al)
8 mg/2,5 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 8 mg/2,5 mg tbl 14x8 mg/2,5 mg (blis.OPA/Al/PVC/Al)
8 mg/2,5 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 8 mg/2,5 mg tbl 20x8 mg/2,5 mg (blis.OPA/Al/PVC/Al)
8 mg/2,5 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 8 mg/2,5 mg tbl 28x8 mg/2,5 mg (blis.OPA/Al/PVC/Al)
8 mg/2,5 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 8 mg/2,5 mg tbl 30x8 mg/2,5 mg (blis.OPA/Al/PVC/Al)
8 mg/2,5 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|
|
Co-Prenessa 8 mg/2,5 mg tbl 50x8 mg/2,5 mg (blis.OPA/Al/PVC/Al)
8 mg/2,5 mg
|
Tableta |
C09BA04
|
KRKA, d.d., Novo mesto |
—
|